Uses
Risevistinel (NYX-783) is a positive allosteric modulator of N-methyl-D-aspartate (NMDA) receptor. Nevadistinel can be used to inhibit cognitive impairment associated with neurodegenerative diseases, such as mild cognitive impairment, mild Alzheimer's disease, Parkinson's disease, Lewy body disease[1].
References
[1] Moskal, et al. Methods of treating disorders associated with elevated levels of antibodies that interact with the NMDA receptor by administering a spiro-β-lactam compound. World Intellectual Property Organization, WO2021021996 A1. 2021-02-04.
